Divi's Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 18,550 million compared to INR 17,080 million a year ago. Revenue was INR 19,500 million compared to INR 18,210 million a year ago. Net income was INR 3,580 million compared to INR 3,060 million a year ago. Basic earnings per share from continuing operations was INR 13.5 compared to INR 11.56 a year ago. Diluted earnings per share from continuing operations was INR 13.5 compared to INR 11.56 a year ago.
For the nine months, sales was INR 55,420 million compared to INR 58,170 million a year ago. Revenue was INR 58,040 million compared to INR 60,990 million a year ago. Net income was INR 10,620 million compared to INR 15,020 million a year ago. Basic earnings per share from continuing operations was INR 40.02 compared to INR 56.6 a year ago. Diluted earnings per share from continuing operations was INR 40.02 compared to INR 56.6 a year ago.